Now showing items 1-2 of 2

    • Materials to enable and enhance T-cell immunotherapies 

      Zhang, Kongyu (2021-11-16)
      Immunotherapies involving engineered T cells have shown remarkable clinical outcomes for the treatment of cancer, particularly hematological malignancies, such as leukemia and lymphoma. However, several barriers need to ...
    • Optimizing the Efficacy of Adoptive T Cell Transfers and CAR-T Therapies 

      Liu, Yutong (2023-05-02)
      Adoptive T cell therapy (ACT), including chimeric antigen receptor (CAR) T cell therapy, is a type of immunotherapy that typically uses a patient’s own T cells to treat tumors. While ACT has demonstrated tremendous success ...